Evidence map›Paper›PMID 41663788›Full record

ReviewMetabolomics : Official journal of the Metabolomic Society2026

What's in a name? Metabolite identification: challenges and pitfalls in untargeted metabolomics.

Georgios Theodoridis, Oliver Fiehn, Michal Holčapek, Royston Goodacre, Daniel Raftery, Robert Plumb, Timothy M D Ebbels, Michael Witting, Helen Gika, Ian D Wilson

Erratum issuedAbstract readReview
In one paragraph

Review in Metabolomics : Official journal of the Metabolomic Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Georgios TheodoridisDepartment of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, 54124, Greece.ORCID http://orcid.org/0000-0002-2015-108X
Oliver FiehnWest Coast Metabolomics Center, UC Davis Genome Center, University of California, 451 Health Sciences Drive, Davis, CA, USA.ORCID http://orcid.org/0000-0002-6261-8928
Michal HolčapekDepartment of Analytical Chemistry, Faculty of Chemical Technology, University of Pardubice, Studentská 573, Pardubice, 53210, Czech Republic.ORCID http://orcid.org/0000-0003-3978-1249
Royston GoodacreCentre for Metabolomics Research, Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, BioSciences Building, Crown St, Liverpool, L69 7ZB, UK.ORCID http://orcid.org/0000-0003-2230-645X
Daniel RafteryNorthwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington, 850 Republican St, Seattle, WA, 98109, USA.ORCID http://orcid.org/0000-0003-2467-8118
Robert PlumbWaters Corporation, 34 Maple St, Milford, MA, USA.ORCID http://orcid.org/0000-0002-1380-9285
Timothy M D EbbelsDivision of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, Hammersmith Campus, London, W12 0NN, UK.ORCID http://orcid.org/0000-0002-3372-8423
Michael WittingMetabolomics and Proteomics Core, Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-1462-4426
Helen GikaBiomic AUTh, Center for Interdisciplinary Research and Innovation (CIRI- AUTH), Balkan Center B1.4, 10th km Thessaloniki-Thermi Rd, P.O. Box 8318, Thessaloniki, 57001, Greece.ORCID http://orcid.org/0000-0002-1893-937X
Ian D WilsonCentre for Metabolomics Research, Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, BioSciences Building, Crown St, Liverpool, L69 7ZB, UK. i.wilson@imperial.ac.uk.ORCID http://orcid.org/0000-0002-8558-7394

Funding

A reproducible database for untargeted metabolomics data processing across laboratoriesR01GM155383 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHARLES ROBERT EVANS, Oliver Fiehn · 2024 to 2026
$1.5M
Quantitative Analysis of Labile Metabolites in Biological SamplesR01GM138465 · NIGMS · UNIVERSITY OF WASHINGTON · PI GOWDA, G. A. NAGANA, RAFTERY, DANIEL · 2021 to 2024
$1.5M
NIGMS NIH HHS R01 GM138465NIGMS NIH HHS R01 GM155383
6 · The paper itself

Abstract

backgroundThe aim of metabolic phenotyping (metabotyping) is to discover and identify metabolites (including lipids) that can be used to characterize biological samples and differentiate between different physiological states. The identification of the metabolites responsible for this differentiation is essential if mechanistic understanding is to be obtained. Confident metabolite identification arguably represents the most important outcome of untargeted metabolomics studies but currently the standards used for metabolite identification reported in many publications do not strictly follow the various published guidelines and thus these identifications lack sufficient proof. AIM OF REVIEW: In this perspective we define problems that currently plague the field of metabolite identification using MS-based techniques, particularly LC-MS, in untargeted metabolic phenotyping. Despite considerable efforts by the community (researchers, instrument manufacturers, software, and database developers) this continues to be a contentious and error-prone step in the metabolomics workflow. The majority of publications provide only sparse data on the evidence for metabolic markers "identified" and we have observed an alarming increase in the frequency of erroneous metabolite identifications. Here, we describe the problem and provide several illustrative case studies. Our goal is to raise awareness and highlight the issue of poor metabolite identification, since it is also increasingly apparent that these errors are not always recognised during the reviewing process, such that papers with potentially erroneous metabolite identities reach publication. KEY SCIENTIFIC CONCEPTS OF REVIEW: Poor metabolite identification potentially represents an existential threat to the credibility of untargeted "discovery" metabolomics and can pollute the literature. Here we describe the aetiology of the problem and explain how and why this issue affects the field. We argue that coordinated action is required by researchers, database managers, scientific societies and the reviewers, editors and publishers of scientific journals to both acknowledge and address this important problem.

Indexed as

MetabolomicsBiomarkersHumansLiquid Chromatography-Mass SpectrometryMass SpectrometryMetabolomeBiomarkersBiomarkersLipidomicsMass spectrometryMetabolite annotationMetabonomicsResearch integrity

Identifiers

PMID41663788
PMCPMC12886295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.